This site is intended for healthcare professionals
Search

Find disease awareness content and relevant supporting materials

Drug information
25/03/19

Esomeprazole 20 mg gastro-resistant tablets and Esomeprazole 40 mg gastro-resistant tablets

Esomeprazole 20 mg gastro-resistant tablets: Esomeprazole 20 mg gastro-resistant tablets are indicated for: Adults Gastroesophageal Reflux Disease (GERD) - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (GERD) In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori and - healing of Helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers. Patients requiring continued NSAID therapy Healing of gastric ulcers associated with NSAID therapy. Prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk. Treatment of Zollinger Ellison Syndrome Adolescents from the age of 12 years Gastroesophageal Reflux Disease (GERD) - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (GERD) In combination with antibiotics in treatment of duodenal ulcer caused by Helicobacter pylori Esomeprazole 40 mg gastro-resistant tablets : Esomeprazole 40 mg gastro-resistant tablets are indicated for: Adults Gastroesophageal Reflux Disease (GERD) - treatment of erosive reflux esophagitis. Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers. Treatment of Zollinger Ellison Syndrome Adolescents from the age of 12 years Gastroesophageal Reflux Disease (GERD) - treatment of erosive reflux esophagitis